Surfactant function in children with chronic airway inflammation

A Braun1, M Steinecker, S Schumacher

  • 1Children's Hospital, Ludwig Maximilians University, Lindwurmstrasse 4, 80337 Munich, Germany.

Insights

Chronic airway inflammation in children, even with mild symptoms, impairs pulmonary surfactant function. This dysfunction, linked to increased neutrophils, may worsen airflow restrictions and contribute to chronic respiratory issues.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology
  • Biochemistry

Background:

  • Pulmonary surfactant maintains airway patency.
  • The impact of mild airway inflammation on surfactant function in children is not well understood.
  • Chronic airway inflammation can lead to airflow limitations.

Purpose of the Study:

  • To investigate whether mild to moderate airway inflammation affects pulmonary surfactant function in children.
  • To determine if impaired surfactant function contributes to chronic airway inflammation pathogenesis.
  • To correlate neutrophil counts with surfactant function in pediatric airway inflammation.

Main Methods:

  • Comparison of surfactant function in children with chronic obstructive bronchitis, asymptomatic tracheostomy patients, and healthy controls.
  • Separation of bronchoalveolar lavage fluid into large surfactant aggregates and inhibitory supernatant.
  • Assessment of surfactant function using a capillary surfactometer with native and reconstituted surfactant mixtures.

Main Results:

  • Pulmonary surfactant function was reduced in children with chronic obstructive bronchitis and tracheostomy compared to controls.
  • Surfactant function inversely correlated with neutrophil counts in bronchoalveolar lavage fluid across all groups.
  • Reconstituted bovine surfactant activity was impaired in children with tracheostomy, suggesting inhibitory factors in their airways.

Conclusions:

  • Chronic lower airway inflammation, even with minimal clinical symptoms, is associated with impaired pulmonary surfactant function.
  • Neutrophil presence in airways correlates with reduced surfactant activity.
  • Surfactant dysfunction may be a contributing factor to airflow restrictions in children with chronic airway inflammation.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...